Cyramza Gains Colon Cancer Indication

The FDA has expanded the indication of Cyramza (ramucirumab; Eli Lilly) for use in combination with irinotecan, folinic acid, and 5-fluorouracil (FOLFIRI) for the treatment of patients with metastatic colorectal cancer (mCRC) whose disease has progressed on a first line bevacizumab-, oxaliplatin- and fluoropyrimidine-containing regimen.

Fish Oil May Hinder Chemotherapy Effectiveness

Fish oil supplements, and even certain fish, may hinder the effectiveness of chemotherapy.

Stroke Risk Up After Cancer Diagnosis

Cancer increases the risk of stroke independently of other stroke risk factors, such as hypertension and diabetes.

Looking for a Job?

Access our job board to view over 1,​40​0 job openings throughout the US.

Proton Pump Inhibitors, Gastric Pre-Cancerous Lesions

It has been suggested that long-term use of proton pump inhibitors (PPIs) may promote the development of pre-cancerous lesions in the stomach and increase the occurrence of stomach cancer.

Vaccine Could Prevent Most Cervical Cancers

A vaccine meant to protect against nine types of human papillomavirus (HPV) could prevent 90% of all cervical cancers.

Obese CRC Patients, Second Cancer Risk

Colorectal cancer (CRC) patients who are overweight or obese when diagnosed appear to face a slightly higher risk for developing a second weight-related cancer.

Prostate Cancer Treatments

Review this new chart on FDA-approved prostate cancer treatments for quick information when you need it.


AANS: Surgeon Volume Affects Costs in Pituitary Tumor Care

AANS: Surgeon Volume Affects Costs in Pituitary Tumor Care

For patients with transsphenoidal pituitary tumors, hospital charges, costs, and length of stay are increased with lower-volume surgeons, according to a study presented at the annual meeting of the American Association of Neurological Surgeons.

DNA Changes May Point to Cancer Years Before Diagnosis

DNA Changes May Point to Cancer Years Before Diagnosis

For the first time, researchers have identified a pattern of change in DNA that may signal the development of cancer long before a standard diagnosis can be made.

Venetoclax Desginated Breakthrough Therapy for CLL

The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to venetoclax (AbbVie ) for the treatment of chronic lymphocytic leukemia (CLL) in previously treated (relapsed/refractory) patients with the 17p deletion genetic mutation.

Risk of All Cancers, Specific Cancers Up in Infertile Men

Risk of All Cancers, Specific Cancers Up in Infertile Men

Infertile men have increased risk of all cancers and some individual cancers.

Cancer Tx Recalled Due to Visible Particulate Matter

The Food and Drug Administration (FDA) announced that Teva Parenteral Medicines is voluntarily recalling eight lots of Adrucil (fluorouracil injection) due to the potential presence of visible foreign particulate matter.


Make prescribing decisions with our comparative charts and treatment algorithms.

Patient Information Fact Sheets

Download or print easy-to-read disease leaflets for your patients.

Featured courses from myCME

Comprehensive Review of Radiation OncologyExternal web site

Radiation oncologists and residents will appreciate the experience of the renowned faculty of the Comprehensive ...

CME 24.00 Credits

Chronic Pain ManagementExternal web site

This activity is designed to change health provider attitudes on chronic pain and willingness to ...

CME|CE 2.00 Credits

HPV Shots for Boys Might Cut Cancer CostsExternal web site

Among the many issues clinicians face today, staying current with advances in medicine is becoming ...

CME|CE 0.25 Credits

Sign Up for Free e-newsletters